Business November 26, 2020
ATAI Life Sciences Inks $125 Million Fundraising Deal for Psychedelic Drugs Development
ATAI Life Sciences, a Berlin-based startup focused on developing psychedelic drugs to treat mental health disorders, said that it had…
Business November 26, 2020
ATAI Life Sciences, a Berlin-based startup focused on developing psychedelic drugs to treat mental health disorders, said that it had…
By Sean Corliss